AstraZeneca’s (AZN) “Sector perform” Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their sector perform rating on shares of AstraZeneca (LON:AZN) in a research report sent to investors on Tuesday,Digital Look reports. The firm currently has a £115 target price on the biopharmaceutical company’s stock.

Other analysts have also recently issued reports about the stock. Jefferies Financial Group restated a “buy” rating and set a £175 target price on shares of AstraZeneca in a report on Monday. Citigroup raised their price objective on AstraZeneca from £175 to £178 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Finally, Berenberg Bank restated a “buy” rating and issued a £160 target price on shares of AstraZeneca in a report on Tuesday, July 28th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of £152.17.

AstraZeneca Trading Down 1.5%

Shares of AZN stock opened at £118.50 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 0.89 and a debt-to-equity ratio of 64.10. The stock has a 50-day simple moving average of £132.34 and a 200 day simple moving average of £139.58. AstraZeneca has a fifty-two week low of £107.84 and a fifty-two week high of £157.32. The stock has a market capitalization of £183.78 billion, a P/E ratio of 17.74, a P/E/G ratio of 0.86 and a beta of 0.23.

About AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.